(Updates with detail on IPO terms)
MADRID (Thomson Financial) - Spanish bourse regulator, the CNMV, said in a statement it has authorised the IPO prospectuses for Laboratorios Almirall SA and Solaria Energia y Medioambiente SA.
Almirall, a pharmaceutical company has scheduled its IPO for June 20, according to the prospectus, while Solaria, which manufactures solar power equipment, will make its market debut on June 19.
Almirall plans to list 27.27 pct of the company, with a further 2.73 pct allocated to a greenshoe option for the placing bank Morgan Stanley.
Of the total, 24.6 pct, or 11.17 mln shares will be attributed to the retail tranche of the offering while 75 pct, or 33.97 mln shares will be allocated to institutional investors.
A further 0.32 pct, or 147,223 shares will be designated for employees of the company.
The company also set an indicative price range of 12.50-15.50 eur per share for the IPO, and will announce the maximum price for the retail tranche on June 12, followed by a final price on June 18.
Meanwhile, Solaria said it will list 23.1 pct of the company, or 23.38 mln shares, increasing to 26.6 pct including the greenshoe option.
The indicative price range for the offering is 7-9.5 eur per share and the company seeks the entire listing to be taken by institutional investors prepared to invest at least 50,000 eur.
The final price will be set on June 17, the company said. tfn.europemadrid@thomson.com cve/jfr/cve/dca COPYRIGHT Copyright AFX News Limited 2007. All rights reserved. The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.
© 2007 AFX News